论文部分内容阅读
目前，对于子宫内膜癌腔内放疗尚无统一的剂量参考卢、。本文以Ａ、Ｆ声、作为剂量参考点，对２６例子宫内膜癌行术前腔内放疗，并在放疗结束后６～９周手术切除子宫，标本行多处取材镜检。２例因合并严重内科疾病而不能手术者，给予腔内和体外放疗，于放疗结束后３个月行内膜活检。结果：２６例术前放疗者１３例子宫内未见肿瘤残存。肿瘤残存程度随Ｆ点剂量增高而减轻。放射损伤的肿瘤细胞随时间延长可进一步消亡。说明子宫内膜癌是一种对放射线较为敏感的肿瘤，Ａ、Ｆ点作为子宫内膜癌腔内放疗的剂量参考点是比较合理的，可供临床参考使用。
At present, there is no uniform dose reference for intraluminal radiotherapy of endometrial cancer. In this paper, A, F sound, as a dose reference point, 26 cases of endometrial cancer preoperative intracavitary radiotherapy, and 6 to 9 weeks after the end of radiotherapy for surgical removal of the uterus, specimens taken multiple microscopic examination. Two patients who were unable to undergo surgery due to severe internal medical conditions were treated with intracavitary and external radiotherapy and endometrial biopsy was performed 3 months after the end of radiotherapy. Results: No tumor remained in 13 cases of uterus in 26 cases of preoperative radiotherapy. Tumor remnants increased with dose of F point to reduce. Radiation-damaged tumor cells may further die over time. That endometrial cancer is a radiation-sensitive tumors, A, F point as endometrial cancer cavity radiation dose reference point is more reasonable for clinical reference.